Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CYCN

Cyclerion Therapeutics Inc

May 08 • 04:00PM ET

3.10

-0.05 -1.59 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BIVI PRQR LCTX PALI BCDA

| Held by: ONEQ VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	30.84%	Shs Outstand	3.82M	Perf Week	-4.91%
Market Cap	13.42M	Forward P/E	-	EPS next Y	-0.99	Insider Trans	0.00%	Shs Float	3.00M	Perf Month	-1.90%
Enterprise Value	10.18M	PEG	-	EPS next Q	-	Inst Own	19.51%	Short Float	8.91%	Perf Quarter	181.82%
Income	-3.53M	P/S	6.48	EPS this Y	10.45%	Inst Trans	1.70%	Short Ratio	0.06	Perf Half Y	77.14%
Sales	2.07M	P/B	1.30	EPS next Y	17.50%	ROA	-36.07%	Short Interest	0.27M	Perf YTD	144.09%
Book/sh	2.38	P/C	4.14	EPS next 5Y	-	ROE	-39.34%	52W High	8.48 -63.44%	Perf Year	-1.82%
Cash/sh	0.75	P/FCF	-	EPS past 3/5Y	62.04% 53.53%	ROIC	-38.83%	52W Low	1.03 201.97%	Perf 3Y	-47.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	91.14% -2.01%	Gross Margin	-	Volatility	4.75% 7.60%	Perf 5Y	-94.38%
Dividend TTM	-	EV/Sales	4.92	EPS Y/Y TTM	3.82%	Oper. Margin	-239.78%	ATR (14)	0.33	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.15	Sales Y/Y TTM	3.70%	Profit Margin	-170.11%	RSI (14)	52.80	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.15	EPS Q/Q	-200.43%	SMA20	0.24%	Beta	1.82	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-43.24%	SMA50	24.15%	Rel Volume	0.01	Prev Close	3.15
Employees	1	LT Debt/Eq	0.00	Earnings	Mar 25	SMA200	49.94%	Avg Volume	4.65M	Price	3.10
IPO	Mar 18, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% 0.00%	Trades		Volume	54,725	Change	-1.59%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)